aap Implantate AG
- WKN: 506660
- ISIN: DE0005066609
- Land: Deutschland
Nachricht vom 01.10.2018 | 13:55
aap receives funding for its innovative antibacterial silver coating technology
DGAP-News: aap Implantate AG / Key word(s): Study/Financing
aap Implantate AG ("aap") announces that its innovative antibacterial silver coating technology receives funding from the German Federal Ministry of Education and Research ("BMBF"). aap shall first receive grants for costs arising within the scope of the preparation of the human clinical study for the aimed market approval of the silver coating technology of up to around EUR 0.7 million. The funding relates in particular to expenses in connection with the conception and qualification of the study. In a next step aap also aims to receive a funding to carry out the human clinical study, for which, however, a further application will be required.
The BMBF funding underlines the innovative character of aap's silver coating technology and its potential to significantly disburden healthcare systems at the cost level. The internationally IP-protected silver coating technology developed by aap is intended to protect the surface of implants from colonisation by bacteria. Thereby aap is addressing one of the biggest not adequately solved challenges in trauma: the reduction of surgical site infection (SSI) risks.
The benefit granted to the company (aap's contract number is 13GW0313A+B) is part of the "Healthcare Industry in the Medical Research Framework Programme" action area of the BMBF (= grant authority). It is granted, according to the BMBF, for projects on "Transferring Medical Technology Solutions to Patient Care - Verifying Clinical Evidence without Delay". As part of the funding programme small and medium-sized businesses (SMBs) are to be introduced to changing legal and regulatory framework conditions and assisted with the clinical validation of medical technology solutions. The swift transfer of innovations to healthcare is thereby to be promoted and the late failure risk of investments in research and development to be reduced. For further information please see the guidelines on the BMBF website at: https://www.bmbf.de/foerderungen/ bekanntmachung-1376.html.
Der AKTIONÄR News
16. Januar 17:01 800%-Strategie: Union Pacific unter Volldampf
16. Januar 17:00 DAX trotzt dem Brexit-GAU - Kaufsignal in Schlagdistanz
16. Januar 16:48 Okta – Cybersecurity-Spezialist liefert satte Kursgewinne
News im Fokus
Deutsche Post AG: Deutsche Post AG nimmt Stellung zur beabsichtigten Entscheidung zur Preisregulierung
15. Januar 2019, 13:37
Original-Research: aventron AG (von First Berlin Equity Research GmbH): Buy aventron AG
16. Januar 2019